Paulino Álvarez

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.1K citations · Full text

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +2

Persistent Blood Stream Infection in Patients Supported With a Continuous-Flow Left Ventricular Assist Device Is Associated With an Increased Risk of Cerebrovascular Accidents

Barry Trachtenberg, Andrea M. Cordero‐Reyes, Molham Aldeiri et al. · Journal of Cardiac Failure · 2014 · 97 citations

Heart Failure, Device Therapy, Cardiovascular Disease +9

Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement

Amgad Mentias, Marwan Saad, Saket Girotra et al. · JACC: Cardiovascular Interventions · 2019 · 93 citations · Full text

New-onset Atrial Fibrillation, Cardiovascular Disease, Valve Disease +8

Trends in Utilization, Mortality, Major Complications, and Cost After Left Ventricular Assist Device Implantation in the United States (2009 to 2014)

Αlexandros Briasoulis, Chakradhari Inampudi, Emmanuel Akintoye et al. · The American Journal of Cardiology · 2018 · 56 citations

Heart Failure, Device Therapy, Medicine +10

Incidence and long-term outcome of heart transplantation patients who develop postoperative renal failure requiring dialysis

Satoshi Shoji, Toshiki Kuno, Shun Kohsaka et al. · The Journal of Heart and Lung Transplantation · 2021 · 40 citations

Transplantation Surgery, Hemodialysis, Heart Failure +14